| Name | (2R,3R,4R,5R)-2-(acetoxymethyl)-5-(2-chloro-9H-purin-9-yl)tetrahydrofuran-3,4-diyl diacetate |
|---|---|
| Synonyms |
2-chloro-9-(2,3,5-tri-O-acetyl-beta-D-ribofuranosyl)-9H-purine
2-Amino-9-[(2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)]-9H-purine 9H-Purine, 2-chloro-9-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl) 9-(2',3',5'-Tri-O-benzoyl-b-D-ribofuranosyl)-2-chloropurine 2-Chloro-9-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-9H-purine |
| Description | 2-Chloro-9-[(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)]-9H-purine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C16H17ClN4O7 |
|---|---|
| Molecular Weight | 412.78 |
| Exact Mass | 412.07900 |
| PSA | 131.73000 |
| LogP | 0.80360 |
|
~87%
1260177-41-0 |
| Literature: Gillerman, Irina; Fischer, Bilha Journal of Medicinal Chemistry, 2011 , vol. 54, # 1 p. 107 - 121 |
| Precursor 1 | |
|---|---|
| DownStream 1 | |